StockViz
RANKINGS
Themis Medicare Limited
NSE:THEMISMED.NS
Sector
Location
Market Cap
USD 137.01 M
Share Price
USD 1.49
Avg Daily Volume
169,424
Change (1 day)
0.99%
Change (1 year)
-39.59%
Change (YTD)
-51.68%
Themis Medicare Limited Income Statement 2015 - 2025
This table shows the Income Statement for Themis Medicare Limited going from 2015 until 2025. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement
| Annual data in millions of USD, except per share data | Trend |
|---|
Competitors
Chugai Pharmaceutical Co., Ltd.
USD 48.89
4519.T
+0.35
0.72%
West Pharmaceutical Services, Inc.
USD 222.26
WST
+1.04
0.47%
Avantor, Inc.
USD 13.88
AVTR
-0.01
-0.07%
Yuhan Corporation
USD 78.07
000100.KS
-2.51
-3.12%
SCHOTT Pharma AG & Co. KGaA
USD 31.21
1SXP.F
-0.17
-0.54%
Gan & Lee Pharmaceuticals.
USD 7.85
603087.SS
-0.05
-0.57%
Zhejiang Huahai Pharmaceutical Co., Ltd.
USD 3.19
600521.SS
+0.13
4.17%
Cohance Lifesciences Limited
USD 11.64
COHANCE.NS
-0.16
-1.35%
Tonghua Dongbao Pharmaceutical Co., Ltd.
USD 1.13
600867.SS
-0.00
-0.10%
Anhui Anke Biotechnology (Group) Co., Ltd.
USD 1.24
300009.SZ
-0.01
-0.42%
Gerresheimer AG
USD 57.42
GXI.DE
-0.09
-0.15%
Tsumura & Co.
USD 24.27
4540.T
-0.05
-0.20%
Neuland Laboratories Limited
USD 136.95
NEULANDLAB.NS
+0.29
0.21%
Blue Jet Healthcare Limited
USD 10.04
BLUEJET.NS
-0.13
-1.32%
Eli Lilly and Company
USD 780.10
LLY
+0.82
0.10%
Johnson & Johnson
USD 156.01
JNJ
+0.45
0.29%
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Roche Holding AG
USD 344.49
RO.SW
-3.19
-0.92%
AstraZeneca PLC
USD 139.36
AZN.L
-2.26
-1.60%
Merck & Co., Inc.
USD 80.96
MRK
-1.43
-1.74%